💲Economic Evaluation for Health Technologies

Summary

• This guide demystifies how HealthTech innovators can present strong economic arguments for NHS adoption by conducting Budget Impact Analyses (BIA) and Cost-Effectiveness Analyses (CEA).
• It explains the role of these tools in NHS decision-making, particularly for reimbursement and procurement, and offers a structured approach aligned with NICE guidelines.
• The content positions BIA as essential for showing financial feasibility, while CEA helps demonstrate long-term value for money.

What this carousel covers

• Definitions and differences between BIA and CEA, and when to use each
• The five-step process for conducting a BIA: identifying the population, defining the time horizon, estimating costs, analysing treatment mix, and reporting results
• Key factors like uptake assumptions, condition-related costs, and health system features that influence outcomes
• Tools and resources, including the NICE BIA template and examples from published evaluations

Key takeaways

• BIAs help NHS buyers understand what your product will cost them in the short-to-mid term, while CEAs address whether it’s worth it long-term
• Presenting results in simple, clear terms—ideally using tools like cost calculators—makes your case easier to act on
• Assumptions around patient numbers, pathway changes, and cost avoidance need to be grounded in NHS-specific data
• Done right, economic evaluations speak the language of procurement teams and dramatically increase your product’s chance of success

‍